Wilson Sonsini Goodrich & Rosati advised LuxWall on IP and patent strategy for the transaction. LuxWall, a leader in glass-based transparent insulation solutions to reduce energy...
LuxWall’s $51 Million Series B Funding Round
Cytovale’s $100 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati advised Cytovale on intellectual property strategy generally and advised the company on IP matters related to the transaction. Cytovale, a commercial-stage...
Aspect Biosystems’ $2.7 Billion Collaboration with Novo Nordisk
Wilson Sonsini Goodrich & Rosati advised Aspect Biosystems on the transaction. Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, and leading global...
Replay’s $55 Million Seed Funding
Wilson Sonsini advised Replay on the deal. Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced its launch with $55 million...